General Information of the Compound
Compound ID |
CP0003153
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(3E)-3-[(2-chloro-1H-indol-3-yl)methylidene]-1H-indol-2-one
Show/Hide
|
||||||||||||||||||
Synonyms |
(3E)-3-[(2-chloro-1H-indol-3-yl)methylidene]-1H-indol-2-one
220749-41-7
3-(2-Chloro-3-indolylmethylene)-1,3-dihydroindol-2-one
3-[(2-Chloro-1H-indole-3-yl)methylene]-1H-indole-2(3H)-one
AC1NV88J
BDBM50375670
BRD-K81836716-001-01-7
CCG-206822
CHEBI:113538
CHEMBL261425
Cdk1 inhibitor
GTPL5944
HMS3229C12
HSCI1_000249
J-014469
K00028
NSC-720148
NSC720148
RT-011955
SCHEMBL1394886
cdk1 inhibitor
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C17H11ClN2O
|
||||||||||||||||||
Molecular Weight |
294.741
|
||||||||||||||||||
Canonical SMILES |
Clc1[nH]c2ccccc2c1\C=C1\C(=O)Nc2ccccc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C17H11ClN2O/c18-16-12(10-5-1-3-7-14(10)19-16)9-13-11-6-2-4-8-15(11)20-17(13)21/h1-9,19H,(H,20,21)/b13-9+
Show/Hide
|
||||||||||||||||||
InChIKey |
QJKBRWSJWQVKLY-UKTHLTGXSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00980, Aurora kinase A
Protein ID: PT01223, Aurora kinase B
Clinical Information about the Compound